Low expression of DDX5 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma.
Masashi MorimachiKenichi HirabayashiYumi TakanashiAya KawanishiTsubasa SaikaYumiko UeyamaToshio NakagohriNaoya NakamuraHidekazu SuzukiTatehiro KagawaPublished in: Journal of clinical pathology (2020)
These results suggest that DDX5 plays an important role in tumour invasiveness and PDAC prognosis.
Keyphrases